Product Information
MS CONTIN ER 15 MG TABLET is a brand product labeled by Rhodes Pharmaceuticals L.P., priced at $4.6807 per EA under NDC 42858051501. Its NADAC has been published 110 times since May 22, 2024.
Strength
15 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858051501
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
7/1/2025
Active Ingredients
MORPHINE SULFATEApproval Type
New Drug (NDA)
FDA Application
NDA019516On Market Since
5/15/2017
Pharmacological Classes
Price Statistics
The NADAC for MS CONTIN ER 15 MG TABLET has been published 110 times since May 22, 2024, and over the history we have for it it has risen 15.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.6807 per EA |
|---|---|
| All-time high | $4.6807 (Jun 24, 2026) |
| All-time low | $4.0400 (May 22, 2024) |
| 52-week high | $4.6807 |
| 52-week low | $4.6807 |
| Median price | $4.4046 |
| Average price | $4.5281 |
| Largest weekly change | +9.0% (Jun 5, 2024) |
| Weeks tracked | 110 |
| Tracking since | May 22, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MS CONTIN ER 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MS CONTIN ER 15 MG TABLET, manufactured by Rhodes Pharmaceuticals L.P., is $4.6807 per EA (NDC 42858051501), effective Jun 24, 2026.
How has the price of MS CONTIN ER 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for MS CONTIN ER 15 MG TABLET has risen 15.9%. It has been tracked across 110 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for MS CONTIN ER 15 MG TABLET?
Since May 22, 2024, the NADAC for MS CONTIN ER 15 MG TABLET has ranged from a low of $4.0400 (May 22, 2024) to a high of $4.6807 (Jun 24, 2026), with a median of $4.4046 per EA.
Are there cheaper alternatives to MS CONTIN ER 15 MG TABLET?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, MORPHINE SULFATE IR 15 MG TAB, is $0.2354 per EA — about 95% below MS CONTIN ER 15 MG TABLET.
Who manufactures MS CONTIN ER 15 MG TABLET?
MS CONTIN ER 15 MG TABLET (NDC 42858051501) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a brand product.
Related Drugs
Same classification